RT Journal Article
T1 SEOM clinical guideline in nasopharynx cancer (2017).
A1 Pastor, M
A1 Lopez Pousa, A
A1 Del Barco, E
A1 Perez Segura, P
A1 Astorga, B Gonzalez
A1 Castelo, B
A1 Bonfill, T
A1 Martinez Trufero, J
A1 Grau, J Jose
A1 Mesia, R
K1 Locally-advanced disease
K1 Nasopharynx cancer
K1 Recurrent/metastatic disease
K1 Treatment guidelines
AB Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
YR 2017
FD 2017-11-02
LK http://hdl.handle.net/10668/11764
UL http://hdl.handle.net/10668/11764
LA en
DS RISalud
RD Apr 6, 2025